Five to buy
Bioventix
This Surrey-based biotechnology company makes monoclonal antibodies from sheep; they are used in hospital blood tests. The firm receives royalties every time a test is performed, which provides a solid pipeline of revenue for several years after the initial production. That funds “generous dividends” and underpins a “sturdy” balance sheet. Small biotechs are risky, but Bioventix has a good history of staying ahead of trends, and the pipeline includes “promising work on screening programmes for…
